title: Comparison of the natural history of new onset and exacerbated chronic ischemic heart disease. The Chest Pain Study Group.
abstract: To compare the natural history of patients with new onset ischemic heart disease with that of patients with exacerbations of chronic ischemic heart disease, short- and long-term outcomes of 3,465 emergency room patients with acute ischemic heart disease at four community and three university hospitals were evaluated. Acute myocardial infarction was diagnosed in 598 (33%) of the 1,835 patients with a prior history of infarction or angina and 934 (57%) of the 1,630 without such a history (p less than 0.001). Patients with new onset ischemic heart disease with acute myocardial infarction were more likely than patients with infarction and exacerbated chronic ischemic heart disease to have Q wave infarction (57% versus 36%) and to receive thrombolytic therapy (11% versus 5%); they also had higher maximal creatine kinase levels (1,088 +/- 1,299 versus 733 +/- 906 U/liter) (p less than 0.0001 for all three). After adjustment for differences in clinical presentation and initial triage, patients with new onset ischemic heart disease with acute myocardial infarction were less likely than the comparison group to have congestive complications (odds ratio 0.63, 95% confidence interval 0.47 to 0.84, p less than 0.01) but not less likely to have arrhythmic, ischemic or overall complications. Among patients with angina without acute myocardial infarction, patients with new onset ischemic heart disease were less likely to have recurrent ischemic pain and congestive heart failure. In multivariate analysis of long-term follow-up data on 457 patients from one hospital, patients with new onset ischemic heart disease had better cardiovascular survival rates.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Brigham and Women's Hospital, Boston, Massachusetts.
authors.forename: L D
authors.initials: LD
authors.lastname: White
authors.forename: T H
authors.initials: TH
authors.lastname: Lee
authors.forename: E F
authors.initials: EF
authors.lastname: Cook
authors.forename: M C
authors.initials: MC
authors.lastname: Weisberg
authors.forename: G W
authors.initials: GW
authors.lastname: Rouan
authors.forename: D A
authors.initials: DA
authors.lastname: Brand
authors.forename: L
authors.initials: L
authors.lastname: Goldman
mesh_terms: D000208:Acute Disease; D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000453:epidemiology; D002908:Chronic Disease; D003327:Coronary Disease / Q000150:complications* / Q000201:enzymology / Q000401:mortality; D003402:Creatine Kinase / Q000097:blood; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009203:Myocardial Infarction / Q000453:epidemiology; D011379:Prognosis; D015996:Survival Rate
chemical_list: D003402:Creatine Kinase